Document Detail


Modulation of the expression of the VIP receptor by serum factors on the human melanoma cell line IGR39.
MedLine Citation:
PMID:  1314189     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
IGR39 cells, isolated from a human superficial melanoma, display at their surface high and low affinity receptors for the vasoactive intestinal peptide (VIP). When grown in DME medium supplemented with 10% fetal calf serum, cells display 1.6 x 10(5) high affinity (Kd 0.74 nM) and 5.6 x 10(5) low affinity (Kd 55 nM) VIP binding sites per cell. When cultured in a chemically defined medium containing EGF, transferrin, and selenium, IGR39 cells display many neurite-like extensions. Following these morphological changes, the specific [125I]VIP binding is increased four- to fivefold after 6 days in culture. This phenomenon is reversible and is the result of an increased number of VIP binding sites available at the cell surface, without modification of their affinities. The molecular mass of the binding sites is also unchanged whatever cell culture conditions. Increase in [125I]VIP binding is inversely correlated to the serum concentration in the culture medium. When added to the chemically defined medium, sera from various origins as well as some serum substitutes reduce [125I]VIP binding to the same extent as that of the serum. The total cAMP production by VIP-stimulated IGR39 cells is enhanced by a factor of six to seven when cells are cultured in serum-free medium, in good correlation with the increase of VIP binding capacity. These data suggest that factor(s) present in fetal calf serum inhibit(s) the expression of VIP receptor, thus demonstrating the importance of a strict control of cell culture conditions for in vitro studies.
Authors:
C Bellan; C Fabre; J Secchi; J Marvaldi; J Pichon; J Luis
Related Documents :
22061889 - Thermal inactivation of the frozen thawed traditional meat starter culture, pediococcus...
55059 - Effect of anti-alpha-fetoprotein serum on growth and plating efficiency of alpha-fetopr...
7212439 - Optimization of the suspension culture method for in vitro cultivation of babesia bovis.
2864089 - Regulation of acetyl-coa carboxylase by glucagon in hela cells.
3667489 - Routine heat inactivation of serum reduces its capacity to promote cell attachment.
8615619 - Activin a inhibits growth and hexamethylene bisacetamide-induced differentiation in hum...
11264839 - Development and experimental validation of a fluid/structure-interaction finite element...
9402359 - Differential quantitative blood cultures in the diagnosis of catheter-related sepsis in...
21989169 - A novel model of human implantation: 3d endometrium-like culture system to study attach...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Experimental cell research     Volume:  200     ISSN:  0014-4827     ISO Abbreviation:  Exp. Cell Res.     Publication Date:  1992 May 
Date Detail:
Created Date:  1992-05-18     Completed Date:  1992-05-18     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0373226     Medline TA:  Exp Cell Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  34-40     Citation Subset:  IM    
Affiliation:
Institut de Chimie Biologique, CNRS URA 202, Université de Provence, Marseille, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Binding Sites / drug effects
Binding, Competitive / drug effects
Blood Proteins / pharmacology*
Blood Substitutes / pharmacology
Culture Media, Serum-Free / pharmacology
Cyclic AMP / analysis
Dose-Response Relationship, Drug
Down-Regulation
Humans
Organic Chemicals
Receptors, Adrenergic, beta / metabolism
Receptors, Gastrointestinal Hormone / metabolism*
Receptors, Vasoactive Intestinal Peptide
Tumor Cells, Cultured / drug effects,  metabolism
Chemical
Reg. No./Substance:
0/Blood Proteins; 0/Blood Substitutes; 0/Culture Media, Serum-Free; 0/Organic Chemicals; 0/Receptors, Adrenergic, beta; 0/Receptors, Gastrointestinal Hormone; 0/Receptors, Vasoactive Intestinal Peptide; 0/Ultroser G; 60-92-4/Cyclic AMP

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Okadaic acid inhibits sister chromatid separation in mammalian cells.
Next Document:  Hydrocortisone-induced increase of PDGF beta-receptor expression in a human malignant mesothelioma c...